Medplus Health Services Limited — Investor Meet, 26-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

MedPlus reported Q4 FY26 consolidated revenue of INR 1,864.4 Cr and operating EBITDA of INR 107.6 Cr (5.8% margin). FY26 operating cash flow was revised significantly to INR 495.6 Cr. The company added 218 net stores in Q4, with plans for 800 net new stores in FY27, including franchisee outlets. The franchisee model is noted for being profitable from day one for MedPlus. Private label sales are 22% of revenue, with a focus on increasing non-pharma private label assortment. SSSG for mature stores was 17.8% in Q4; annual aim is 9-10%. Management's outlook is to maintain current profitability and grow through strategic expansion.